Gavin, NI, Gaynes, BN, Lohr, KN, Meltzer-Brody, S, Gartlehner, G, Swinson, T. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol. 2005; 106(5 Pt 1): 1071–1083.
Hendrick, V, Altshuler, LL, Suri, R. Hormonal changes in the postpartum and implications for postpartum depression. Psychosomatics. 1998; 39(2): 93–101.
Bloch, M, Schmidt, PJ, Danaceau, M, Murphy, J, Nieman, L, Rubinow, DR. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry. 2000; 157(6): 924–930.
Galea, LA, Wide, JK, Barr, AM. Estradiol alleviates depressive-like symptoms in a novel animal model of post-partum depression. Behav Brain Res. 2001; 122(1): 1–9.
Gregoire, AJ, Kumar, R, Everitt, B, Henderson, AF, Studd, JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet. 1996; 347(9006): 930–933.
Sichel, DA, Cohen, LS, Robertson, LM, Ruttenberg, A, Rosenbaum, JF. Prophylactic estrogen in recurrent postpartum affective disorder. Biol Psychiatry. 1995; 38(12): 814–818.
Stoffel, EC, Craft, RM. Ovarian hormone withdrawal-induced “depression” in female rats. Physiol Behav. 2004; 83(3): 505–513.
Suda, S, Segi-Nishida, E, Newton, SS, Duman, RS. A postpartum model in rat: behavioral and gene expression changes induced by ovarian steroid deprivation. Biol Psychiatry. 2008; 64(4): 311–319.
Buckwalter, JG, Stanczyk, FZ, McCleary, CA, et al. Pregnancy, the postpartum, and steroid hormones: effects on cognition and mood. Psychoneuroendocrinology. 1999; 24(1): 69–84.
Heidrich, A, Schleyer, M, Spingler, H, et al. Postpartum blues: relationship between not-protein bound steroid hormones in plasma and postpartum mood changes. J Affect Disord. 1994; 30(2): 93–98.
O’Hara, MW, Schlechte, JA, Lewis, DA, Varner, MW. Controlled prospective study of postpartum mood disorders: psychological, environmental, and hormonal variables. J Abnorm Psychol. 1991; 100(1): 63–73.
Ahokas, A, Kaukoranta, J, Wahlbeck, K, Aito, M. Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study. J Clin Psychiatry. 2001; 62(5): 332–336.
Beck, CT. Predictors of postpartum depression: an update. Nurs Res. 2001; 50(5): 275–285.
Collins, NL, Dunkel-Schetter, C, Lobel, M, Scrimshaw, SC. Social support in pregnancy: psychosocial correlates of birth outcomes and postpartum depression. J Pers Soc Psychol. 1993; 65(6): 1243–1258.
O’Hara, MW, Swain, AM. Rates and risk of postpartum depression—a meta-analysis. Int Rev Psychiatry. 1996; 8(1): 37–54.
Bloch, M, Rotenberg, N, Koren, D, Klein, E. Risk factors for early postpartum depressive symptoms. Gen Hosp Psychiatry. 2006; 28(1): 3–8.
O’Hara, MW, Neunaber, DJ, Zekoski, EM. Prospective study of postpartum depression: prevalence, course, and predictive factors. J Abnorm Psychol. 1984; 93(2): 158–171.
Schiller, CE, O’Hara, MW, Rubinow, DR, Johnson, AK. Estradiol modulates anhedonia and behavioral despair in rats and negative affect in a subgroup of women at high risk for postpartum depression. Physiol Behav. 2013; 119: 137–144.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed.
Arlington, VA: American Psychiatric Publishing; 2013.
Bernstein, IH, Rush, AJ, Yonkers, K, et al. Symptom features of postpartum depression: are they distinct?
Depress Anxiety. 2008; 25(1): 20–26.
Wisner, KL, Sit, DY, McShea, MC, et al. Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. JAMA Psychiatry. 2013; 70(5): 490–498.
O’Hara, MW. Postpartum Depression: Causes and Consequences. New York: Springer-Verlag; 1995.
Vesga-Lopez, O, Blanco, C, Keyes, K, Olfson, M, Grant, BF, Hasin, DS. Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry. 2008; 65(7): 805–815.
Sit, D, Rothschild, AJ, Wisner, KL. A review of postpartum psychosis. J Womens Health (Larchmt). 2006; 15(4): 352–368.
Wisner, KL, Peindl, K, Hanusa, BH. Symptomatology of affective and psychotic llnesses related to childbearing. J Affect Disord. 1994; 30(2): 77–87.
Brockington, IF, Cernik, KF, Schofield, EM, Downing, AR, Francis, AF, Keelan, C. Puerperal psychosis: phenomena and diagnosis. Arch Gen Psychiatry. 1981; 38(7): 829–833.
Kendell, RE, Chalmers, JC, Platz, C. Epidemiology of puerperal psychoses. Br J Psychiatry. 1987; 150(5): 662–673.
Forty, L, Jones, L, Macgregor, S, et al. Familiality of postpartum depression in unipolar disorder: results of a family study. Am J Psychiatry. 2006; 163(9): 1549–1553.
Deligiannidis, KM, Sikoglu, EM, Shaffer, SA, et al. GABAergic neuroactive steroids and resting-state functional connectivity in postpartum depression: a preliminary study. J Psychiatr Res. 2013; 47(6): 816–828.
Sohrabji, F, Miranda, RC, Toran-Allerand, CD. Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J Neurosci. 1994; 14(2): 459–471.
Shimizu, E, Hashimoto, K, Okamura, N, et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry. 2003; 54(1): 70–75.
Zhou, Y, Watters, JJ, Dorsa, DM. Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain. Endocrinology. 1996; 137(5): 2163–2166.
Sohrabji, F, Greene, LA, Miranda, RC, Toran-Allerand, CD. Reciprocal regulation of estrogen and NGF receptors by their ligands in PC12 cells. J Neurobiol. 1994; 25(8): 974–988.
Cardona-Gomez, P, Perez, M, Avila, J, Garcia-Segura, L, Wandosell, F. Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and beta-catenin in the hippocampus. Mol Cell Neurosci. 2004; 25(3): 363–373.
Finocchi, C, Ferrari, M. Female reproductive steroids and neuronal excitability. Neurol Sci. 2011; 32(Suppl 1): S31–S35.
Pluchino, N, Russo, M, Santoro, AN, Litta, P, Cela, V, Genazzani, AR. Steroid hormones and BDNF. Neuroscience. 2013; 239: 271–279.
Rubinow, DR, Girdler, SS. Hormones, heart disease, and health: individualized medicine versus throwing the baby out with the bathwater. Depress Anxiety. 2011; 28(4): 282–296.
Berman, KF, Schmidt, PJ, Rubinow, DR, et al. Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women. Proc Natl Acad Sci U S A. 1997; 94(16): 8836–8841.
Goldstein, JM, Jerram, M, Poldrack, R, et al. Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging. J Neurosci. 2005; 25(40): 9309–9316.
Protopopescu, X, Pan, H, Altemus, M, et al. Orbitofrontal cortex activity related to emotional processing changes across the menstrual cycle. Proc Natl Acad Sci U S A. 2005; 102(44): 16060–16065.
Dreher, JC, Schmidt, PJ, Kohn, P, Furman, D, Rubinow, D, Berman, KF. Menstrual cycle phase modulates reward-related neural function in women. Proc Natl Acad Sci U S A. 2007; 104(7): 2465–2470.
Santin, AP, Furlanetto, TW. Role of estrogen in thyroid function and growth regulation. J Thyroid Res. 2011; 2011: e875125.
Schumacher, M, Coirini, H, Pfaff, DW, McEwen, BS. Behavioral effects of progesterone associated with rapid modulation of oxytocin receptors. Science. 1990; 250(4981): 691–694.
Walf, AA, Frye, CA. Antianxiety and antidepressive behavior produced by physiological estradiol regimen may be modulated by hypothalamic–pituitary–adrenal axis activity. Neuropsychopharmacology. 2005; 30(7): 1288–1301.
Roca, CA, Schmidt, PJ, Altemus, M, et al. Differential menstrual cycle regulation of hypothalamic-pituitary-adrenal axis in women with premenstrual syndrome and controls. J Clin Endocrinol Metab. 2003; 88(7): 3057–3063.
Butts, CL, Sternberg, EM. Neuroendocrine factors alter host defense by modulating immune function. Cell Immunol. 2008; 252(1–2): 7–15.
Bunevicius, R, Kusminskas, L, Mickuviene, N, Bunevicius, A, Pedersen, CA, Pop, VJM. Depressive disorder and thyroid axis functioning during pregnancy. World J Biol Psychiatry. 2009; 10(4): 324–329.
Placidi, GPA, Boldrini, M, Patronelli, A, et al. Prevalence of psychiatric disorders in thyroid diseased patients. Neuropsychobiology. 1998; 38(4): 222–225.
Gulseren, S, Gulseren, L, Hekimsoy, Z, Cetinay, P, Ozen, C, Tokatlioglu, B. Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Arch Med Res. 2006; 37(1): 133–139.
Berent, D, Zboralski, K, Orzechowska, A, Gałecki, P. Thyroid hormones association with depression severity and clinical outcome in patients with major depressive disorder. Mol Biol Rep. 2014; 41(4): 2419–2425.
Nemeroff, CB, Simon, JS, Haggerty, JJ Jr, Evans, DL. Antithyroid antibodies in depressed patients. Am J Psychiatry. 1985; 142(7): 840–843.
Cooper-Kazaz, R, Lerer, B. Efficacy and safety of triiodothyronine supplementation in patients with major depressive disorder treated with specific serotonin reuptake inhibitors. Int J Neuropsychopharmacol. 2008; 11(5): 685–699.
Cooper-Kazaz, R, Apter, JT, Cohen, R, et al. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry. 2007; 64(6): 679–688.
Ben-Rafael, Z, Struass, JF 3rd, Arendash-Durand, B, Mastroianni, L Jr, Flickinger, GL. Changes in thyroid function tests and sex hormone binding globulin associated with treatment by gonadotropin. Fertil Steril. 1987; 48(2): 318–320.
Arafah, BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med. 2001; 344(23): 1743–1749.
Vaidya, B, Anthony, S, Bilous, M, et al. Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding?
J Clin Endocrinol Metab. 2007; 92(1): 203–207.
Pedersen, CA, Johnson, JL, Silva, S, et al. Antenatal thyroid correlates of postpartum depression. Psychoneuroendocrinology. 2007; 32(3): 235–245.
Pedersen, CA, Stern, RA, Pate, J, Senger, MA, Bowes, WA, Mason, GA. Thyroid and adrenal measures during late pregnancy and the puerperium in women who have been major depressed or who become dysphoric postpartum. J Affect Disord. 1993; 29(2–3): 201–211.
Bloch, M, Daly, RC, Rubinow, DR. Endocrine factors in the etiology of postpartum depression. Compr Psychiatry. 2003; 44(3): 234–246.
Albacar, G, Sans, T, Martín-Santos, R, et al. Thyroid function 48h after delivery as a marker for subsequent postpartum depression. Psychoneuroendocrinology. 2010; 35(5): 738–742.
Kent, GN, Stuckey, BG, Allen, JR, Lambert, T, Gee, V. Postpartum thyroid dysfunction: clinical assessment and relationship to psychiatric affective morbidity. Clin Endocrinol (Oxf). 1999; 51(4): 429–438.
Stuebe, AM, Grewen, K, Pedersen, CA, Propper, C, Meltzer-Brody, S. Failed lactation and perinatal depression: common problems with shared neuroendocrine mechanisms?
J Womens Health (Larchmt). 2012; 21(3): 264–272.
Stuebe, AM, Grewen, K, Meltzer-Brody, S. Association between maternal mood and oxytocin response to breastfeeding. J Womens Health (Larchmt). 2013; 22(4): 352–361.
Amico, JA, Crowley, RS, Insel, TR, Thomas, A, O’Keefe, JA. Effect of gonadal steroids upon hypothalamic oxytocin expression. Adv Exp Med Biol. 1995; 395: 23–35.
Broad, KD, Kendrick, KM, Sirinathsinghji, DJS, Keverne, EB. Changes in oxytocin immunoreactivity and mRNA expression in the sheep brain during pregnancy, parturition and lactation and in response to oestrogen and progesterone. J Neuroendocrinol. 1993; 5(4): 435–444.
Skrundz, M, Bolten, M, Nast, I, Hellhammer, DH, Meinlschmidt, G. Plasma oxytocin concentration during pregnancy is associated with development of postpartum depression. Neuropsychopharmacology. 2011; 36(9): 1886–1893.
Apter-Levy, Y, Feldman, M, Vakart, A, Ebstein, RP, Feldman, R. Impact of maternal depression across the first 6 years of life on the child’s mental health, social engagement, and empathy: the moderating role of oxytocin. Am J Psychiatry. 2013; 170(10): 1161–1168.
Kim, S, Soeken, TA, Cromer, SJ, Martinez, SR, Hardy, LR, Strathearn, L. Oxytocin and postpartum depression: delivering on what’s known and what’s not. Brain Res. 2014; 1580: 219–232.
Mah, BL, Van IJzendoorn, MH, Smith, R, Bakermans-Kranenburg, MJ. Oxytocin in postnatally depressed mothers: its influence on mood and expressed emotion. Prog Neuropsychopharmacol Biol Psychiatry. 2013; 40: 267–272.
Nestler, EJ, Barrot, M, DiLeone, RJ, Eisch, AJ, Gold, SJ, Monteggia, LM. Neurobiology of depression. Neuron. 2002; 34(1): 13–25.
Heim, C, Newport, DJ, Wagner, D, Wilcox, MM, Miller, AH, Nemeroff, CB. The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: a multiple regression analysis. Depress Anxiety. 2002; 15(3): 117–125.
Records, K, Rice, MJ. A comparative study of postpartum depression in abused and nonabused women. Arch Psychiatr Nurs. 2005; 19(6): 281–290.
Ross, LE, Dennis, CL. The prevalence of postpartum depression among women with substance use, an abuse history, or chronic illness: a systematic review. J Womens Health (Larchmt). 2009; 18(4): 475–486.
Mastorakos, G, Ilias, I. Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Ann N Y Acad Sci. 2003; 997: 136–149.
Young, EA. Glucocorticoid cascade hypothesis revisited: role of gonadal steroids. Depression. 1995; 3(1–2): 20–27.
Vamvakopoulos, NC, Chrousos, GP. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression: potential implications for the sexual dimorphism of the stress response and immune/inflammatory reaction. J Clin Invest. 1993; 92(4): 1896–1902.
Jolley, SN, Elmore, S, Barnard, KE, Carr, DB. Dysregulation of the hypothalamic-pituitary-adrenal axis in postpartum depression. Biol Res Nurs. 2007; 8(3): 210–222.
Handley, SL, Dunn, TL, Waldron, G, Baker, JM. Tryptophan, cortisol and puerperal mood. Br J Psychiatry. 1980; 136(5): 498–508.
Corwin, EJ, Pajer, K. The psychoneuroimmunology of postpartum depression. J Womens Health (Larchmt). 2008; 17(9): 1529–1534.
Dowlati, Y, Herrmann, N, Swardfager, W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010; 67(5): 446–457.
Raison, CL, Capuron, L, Miller, AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006; 27(1): 24–31.
Cunningham, M, Gilkeson, G. Estrogen receptors in immunity and autoimmunity. Clin Rev Allergy Immunol. 2011; 40(1): 66–73.
Segman, RH, Goltser-Dubner, T, Weiner, I, et al. Blood mononuclear cell gene expression signature of postpartum depression. Mol Psychiatry. 2010; 15(1): 93–100, 102.
Krause, D, Jobst, A, Kirchberg, F, et al. Prenatal immunologic predictors of postpartum depressive symptoms: a prospective study for potential diagnostic markers. Eur Arch Psychiatry Clin Neurosci. In press. DOI: 10.1007/s00406-014-0494-8.
Blackmore, ER, Moynihan, JA, Rubinow, DR, Pressman, EK, Gilchrist, M, O’Connor, TG. Psychiatric symptoms and proinflammatory cytokines in pregnancy. Psychosom Med. 2011; 73(8): 656–663.
Blackmore, ER, Groth, SW, Chen, DG, Gilchrist, MA, O’Connor, TG, Moynihan, JA. Depressive symptoms and proinflammatory cytokines across the perinatal period in African American women. J Psychosom Obstet Gynaecol. 2013; 35(1): 8–15.
Okun, ML, Luther, J, Prather, AA, Perel, JM, Wisniewski, S, Wisner, KL. Changes in sleep quality, but not hormones predict time to postpartum depression recurrence. J Affect Disord. 2011; 130(3): 378–384.
Murphy-Eberenz, K, Zandi, PP, March, D, et al. Is perinatal depression familial?
J Affect Disord. 2006; 90(1): 49–55.
Treloar, SA, Martin, NG, Bucholz, KK, Madden, PA, Heath, AC. Genetic influences on post-natal depressive symptoms: findings from an Australian twin sample. Psychol Med. 1999; 29(3): 645–654.
Figueira, P, Malloy-Diniz, L, Campos, SB, et al. An association study between the Val66Met polymorphism of the BDNF gene and postpartum depression. Arch Womens Ment Health. 2010; 13(3): 285–289.
Comasco, E, Sylvén, SM, Papadopoulos, FC, Oreland, L, Sundström-Poromaa, I, Skalkidou, A. Postpartum depressive symptoms and the BDNF Val66Met functional polymorphism: effect of season of delivery. Arch Womens Ment Health. 2011; 14(6): 453–463.
Comasco, E, Sylvén, SM, Papadopoulos, FC, Sundström-Poromaa, I, Oreland, L, Skalkidou, A. Postpartum depression symptoms: a case-control study on monoaminergic functional polymorphisms and environmental stressors. Psychiatr Genet. 2011; 21(1): 19–28.
Alvim-Soares, A, Miranda, D, Campos, SB, Figueira, P, Romano-Silva, MA, Correa, H. Postpartum depression symptoms associated with Val158Met COMT polymorphism. Arch Womens Ment Health. 2013; 16(4): 339–340.
Engineer, N, Darwin, L, Nishigandh, D, Ngianga-Bakwin, K, Smith, SC, Grammatopoulos, DK. Association of glucocorticoid and type 1 corticotropin-releasing hormone receptors gene variants and risk for depression during pregnancy and post-partum. J Psychiatr Res. 2013; 47(9): 1166–1173.
Binder, EB, Newport, DJ, Zach, EB, et al. A serotonin transporter gene polymorphism predicts peripartum depressive symptoms in an at-risk psychiatric cohort. J Psychiatr Res. 2010; 44(10): 640–646.
Mitchell, C, Notterman, D, Brooks-Gunn, J, et al. Role of mother’s genes and environment in postpartum depression. Proc Natl Acad Sci U S A. 2011; 108(20): 8189–8193.
El-Ibiary, SY, Hamilton, SP, Abel, R, Erdman, CA, Robertson, PA, Finley, PR. A pilot study evaluating genetic and environmental factors for postpartum depression. Innov Clin Neurosci. 2013; 10(9–10): 15–22.
Costas, J, Gratacòs, M, Escaramís, G, et al. Association study of 44 candidate genes with depressive and anxiety symptoms in post-partum women. J Psychiatr Res. 2010; 44(11): 717–724.
Pinsonneault, JK, Sullivan, D, Sadee, W, Soares, CN, Hampson, E, Steiner, M. Association study of the estrogen receptor gene ESR1 with postpartum depression—a pilot study. Arch Womens Ment Health. 2013; 16(6): 499–509.
Pinheiro, RT, Coelho, FM, Silva, RA, et al. Association of a serotonin transporter gene polymorphism (5-HTTLPR) and stressful life events with postpartum depressive symptoms: a population-based study. J Psychosom Obstet Gynaecol. 2013; 34(1): 29–33.
Mahon, PB, Payne, JL, MacKinnon, DF, et al. Genome-wide linkage and follow-up association study of postpartum mood symptoms. Am J Psychiatry. 2009; 166(11): 1229–1237.
Alvim-Soares, AM, Miranda, DM, Campos, SB, Figueira, P, Correa, H, Romano-Silva, MA. HMNC1 gene polymorphism associated with postpartum depression. Rev Bras Psiquiatr. 2014; 36(1): 96–97.
Mehta, D, Newport, DJ, Frishman, G, et al. Early predictive biomarkers for postpartum depression point to a role for estrogen receptor signaling. Psychol Med. 2014; 44(11): 2309–2322.
Guintivano, J, Arad, M, Gould, TD, Payne, JL, Kaminsky, ZA. Antenatal prediction of postpartum depression with blood DNA methylation biomarkers. Mol Psychiatry. 2014; 19(5): 560–567.
Green, AD, Barr, AM, Galea, LAM. Role of estradiol withdrawal in “anhedonic” sucrose consumption: a model of postpartum depression. Physiol Behav. 2009; 97(2): 259–265.
Bekku, N, Yoshimura, H. Animal model of menopausal depressive-like state in female mice: prolongation of immobility time in the forced swimming test following ovariectomy. Psychopharmacology (Berl). 2005; 183(3): 300–307.
Bernardi, M, Vergoni, AV, Sandrini, M, Tagliavini, S, Bertolini, A. Influence of ovariectomy, estradiol and progesterone on the behavior of mice in an experimental model of depression. Physiol Behav. 1989; 45(5): 1067–1068.
Estrada-Camarena, E, Fernandez-Guasti, A, Lopez-Rubalcava, C. Antidepressant-like effect of different estrogenic compounds in the forced swimming test. Neuropsychopharmacology. 2003; 28(5): 830–838.
Walf, AA, Rhodes, ME, Frye, CA. Antidepressant effects of ERbeta-selective estrogen receptor modulators in the forced swim test. Pharmacol Biochem Behav. 2004; 78(3): 523–529.
Walf, AA, Frye, CA. A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology. 2006; 31(6): 1097–1111.
Maayan, R, Strous, RD, Abou-Kaoud, M, Weizman, A. The effect of 17beta estradiol withdrawal on the level of brain and peripheral neurosteroids in ovarectomized rats. Neurosci Lett. 2005; 384(1–2): 156–161.
Bossé, R, Rivest, R, Di Paolo, T. Ovariectomy and estradiol treatment affect the dopamine transporter and its gene expression in the rat brain. Brain Res Mol Brain Res. 1997; 46(1–2): 343–346.
Di Paolo, T, Poyet, P, Labrie, F. Effect of prolactin and estradiol on rat striatal dopamine receptors. Life Sci. 1982; 31(25): 2921–2929.
Di Paolo, T, Poyet, P, Labrie, F. Prolactin and estradiol increase striatal dopamine receptor density in intact, castrated and hypophysectomized rats. Prog Neuropsychopharmacol Biol Psychiatry. 1982; 6(4–6): 377–382.
Byrnes, EM, Byrnes, JJ, Bridges, RS. Increased sensitivity of dopamine systems following reproductive experience in rats. Pharmacol Biochem Behav. 2001; 68(3): 481–489.
Wenzel, A, Haugen, EN, Jackson, LC, Brendle, JR. Anxiety symptoms and disorders at eight weeks postpartum. J Anxiety Disord. 2005; 19(3): 295–311.
Beckley, EH, Finn, DA. Inhibition of progesterone metabolism mimics the effect of progesterone withdrawal on forced swim test immobility. Pharmacol Biochem Behav. 2007; 87(4): 412–419.
Smith, SS, Gong, QH, Li, X, et al. Withdrawal from 3α-OH-5α-pregnan-20-one using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor α4 subunit in association with increased anxiety. J Neurosci. 1998; 18(14): 5275–5284.
Dennerstein, L, Spencer-Gardner, C, Gotts, G, Brown, JB, Smith, MA, Burrows, GD. Progesterone and the premenstrual syndrome: a double blind crossover trial. Br Med J (Clin Res Ed). 1985; 290(6482): 1617–1621.
Frye, CA, Walf, AA. Hippocampal 3α,5α-THP may alter depressive behavior of pregnant and lactating rats. Pharmacol Biochem Behav. 2004; 78(3): 531–540.
Chatzicharalampous, C, Rizos, D, Pliatsika, P, et al. Reproductive hormones and postpartum mood disturbances in Greek women. Gynecol Endocrinol. 2010; 27(8): 543–550.
Silverman, ME, Loudon, H, Safier, M, et al. Neural dysfunction in postpartum depression: an fMRI pilot study. CNS Spectr. 2007; 12(11): 853–862.
Moses-Kolko, EL, Perlman, SB, Wisner, KL, James, J, Saul, AT, Phillips, ML. Abnormally reduced dorsomedial prefrontal cortical activity and effective connectivity with amygdala in response to negative emotional faces in postpartum depression. Am J Psychiatry. 2010; 167(11): 1373–1380.
Moses-Kolko, EL, Fraser, D, Wisner, KL, et al. Rapid habituation of ventral striatal response to reward receipt in postpartum depression. Biol Psychiatry. 2011; 70(4): 395–399.
Goodyer, IM, Herbert, J, Altham, PM, Pearson, J, Secher, SM, Shiers, HM. Adrenal secretion during major depression in 8- to 16-year-olds, I. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation. Psychol Med. 1996; 26(2): 245–256.
Yaffe, K, Ettinger, B, Pressman, A, et al. Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study. Biol Psychiatry. 1998; 43(9): 694–700.
Heuser, I, Deuschle, M, Luppa, P, Schweiger, U, Standhardt, H, Weber, B. Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients. J Clin Endocrinol Metab. 1998; 83(9): 3130–3133.
Michael, A, Jenaway, A, Paykel, ES, Herbert, J. Altered salivary dehydroepiandrosterone levels in major depression in adults. Biol Psychiatry. 2000; 48(10): 989–995.
Schmidt, PJ, Murphy, JH, Haq, N, Danaceau, MA, St Clair, L. Basal plasma hormone levels in depressed perimenopausal women. Psychoneuroendocrinology. 2002; 27(8): 907–920.
Wolkowitz, OM, Reus, VI, Keebler, A, et al. Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry. 1999; 156(4): 646–649.
Schmidt, P, Daly, RC, Bloch, M, et al. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry. 2005; 62(2): 154–162.
Majewska, MD, Harrison, NL, Schwartz, RD, Barker, JL, Paul, SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 1986; 232(4753): 1004–1007.
Bitran, D, Hilvers, RJ, Kellogg, CK. Anxiolytic effects of 3α-hydroxy-5α[β]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Res. 1991; 561(1): 157–161.
Wieland, S, Lan, NC, Mirasedeghi, S, Gee, KW. Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Brain Res. 1991; 565(2): 263–268.
Bitran, D, Purdy, RH, Kellog, CK. Anxiolytic effect of progesterone is associated with increases in cortical alloprenanolone and GABAA receptor function. Pharmacol Biochem Behav. 1993; 45(2): 423–428.
Smith, SS, Gong, QH, Hsu, FC, Markowitz, RS, ffrench-Mullen, JM, Li, X. GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature. 1998; 392(6679): 926–930.
Uzunova, V, Sheline, Y, Davis, JM, et al. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci U S A. 1998; 95(6): 3239–3244.
Romeo, E, Ströhle, A, Spalletta, G, et al. Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry. 1998; 155(7): 910–913.
Ströhle, A, Romeo, E, Hermann, B, et al. Concentrations of 3α-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol Psychiatry. 1999; 45(3): 274–277.
Schüle, C, Romeo, E, Uzunov, DP, et al. Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3α-hydroxysteroid dehydrogenase activity. Mol Psychiatry. 2005; 11(3): 261–272.
Eser, D, Schüle, C, Baghai, TC, Romeo, E, Rupprecht, R. Neuroactive steroids in depression and anxiety disorders: clinical studies. Neuroendocrinology. 2006; 84(4): 244–254.
Schüle, C, Baghai, TC, di Michele, F, et al. Effects of combination treatment with mood stabilizers and mirtazapine on plasma concentrations of neuroactive steroids in depressed patients. Psychoneuroendocrinology. 2007; 32(6): 669–680.
Patchev, VK, Shoaib, M, Holsboer, F, Almeida, OFX. The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience. 1994; 62(1): 265–271.
Patchev, VK, Hassan, AHS, Holsboer, F, Almeida, OFX. The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology. 1996; 15(6): 533–540.
Barbaccia, ML, Roscetti, G, Trabucchi, M, et al. The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations. Br J Pharmacol. 1997; 120(8): 1582–1588.
Kehoe, P, Mallinson, K, McCormick, CM, Frye, CA. Central allopregnanolone is increased in rat pups in response to repeated, short episodes of neonatal isolation. Brain Res Dev Brain Res. 2000; 124(1–2): 133–136.
Djebaili, M, Guo, Q, Pettus, EH, Hoffman, SW, Stein, DG. The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J Neurotrauma. 2005; 22(1): 106–118.
Sayeed, I, Parvez, S, Wali, B, Siemen, D, Stein, DG. Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism for better neuroprotective effects of allopregnanolone over progesterone. Brain Res. 2009; 1263: 165–173.
He, J, Evans, C-O, Hoffman, SW, Oyesiku, NM, Stein, DG. Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp Neurol. 2004; 189(2): 404–412.
Bixo, M, Andersson, A, Winblad, B, Purdy, RH, Bäckström, T. Progesterone, 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Res. 1997; 764(1–2): 173–178.
Akwa, Y, Purdy, RH, Koob, GF, Britton, KT. The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat. Behav Brain Res. 1999; 106(1–2): 119–125.
Epperson, CN, Gueorguieva, R, Czarkowski, KA, et al. Preliminary evidence of reduced occipital GABA concentrations in puerperal women: a 1H-MRS study. Psychopharmacology (Berl). 2006; 186(3): 425–433.
Schiller, CE, Schmidt, PJ, Rubinow, DR. Allopregnanolone as a mediator of affective switching in reproductive mood disorders. Psychopharmacology (Berl). 2014; 231(17): 3557–3567.
Tarantino, LM, Sullivan, PF, Meltzer-Brody, S. Using animal models to disentangle the role of genetic, epigenetic, and environmental influences on behavioral outcomes associated with maternal anxiety and depression. Front Psychiatry. 2011; 2: 44.
Maguire, J, Mody, I. GABAAR plasticity during pregnancy: relevance to postpartum depression. Neuron. 2008; 59(2): 207–213.
Maguire, JL, Stell, BM, Rafizadeh, M, Mody, I. Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat Neurosci. 2005; 8(6): 797–804.
Maguire, J, Ferando, I, Simonsen, C, Mody, I. Excitability changes related to GABAA receptor plasticity during pregnancy. J Neurosci. 2009; 29(30): 9592–9601.